Percutaneous radiofrequency (RF) thermal ablation has received attention as an effective minimally invasive approach for the treatment of a variety of neoplasms. However, the therapeutic efficacy of RF thermal ablation on primary pleural synovial sarcoma has not yet been reported. A 76-year-old man with a primary pleural synovial sarcoma who was medically inoperable received RF thermal ablation to achieve local control. Therefore, an RF electrode was inserted into the lesion and connected to an RF generator. In this report, a case of successful treatment of a primary pleural synovial sarcoma using RF ablation without complication is presented.

Keywords:
Pleura, Radiofrequency thermal ablation, Synovial sarcoma, Treatment
1.
Enzinger FM, Weiss SW: Soft Tissue Tumors, ed 3. St. Louis, Mosby, 1995, pp 757–786.
2.
Ng SB, Ahmed Q, Tien SL, Sivaswaren C, Lau LC: Primary pleural synovial sarcoma. A case report and review of the literature. Arch Pathol Lab Med 2003;127:85–90.
3.
Nicholson AG, Goldstraw P, Fisher C: Synovial sarcoma of the pleura and its differentiation from other primary pleural tumours: A clinicopathological and immunohistochemical review of three cases. Histopathology 1998;33:508–513.
4.
Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL: Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: An analysis of 225 patients. Cancer 2003;97:2530–2543.
5.
Maruyama R, Mitsudomi T, Ishida T, Saitoh G, Nishioka K, Fukuyama Y, Hamatake M, Sugio K, Sugimachi K: Aggressive pulmonary metastasectomies for synovial sarcoma. Respiration 1997;64:316–318.
6.
Jain SK, Dupuy DE, Cardarelli GA, Zheng Z, DiPetrillo TA: Percutaneous radiofrequency ablation of pulmonary malignancies: Combined treatment with brachytherapy. AJR Am J Roentgenol 2003;181:711–715.
7.
Machtay M, Friedberg JS: The role of radiation therapy in the management of non-small cell lung cancer. Semin Thorac Cardiovasc Surg 1997;9:80–89.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.